Immune Dysregulation in Hepatitis C Patients With or Without Arthritis
Status: | Completed |
---|---|
Conditions: | Arthritis, Hepatitis |
Therapuetic Areas: | Immunology / Infectious Diseases, Rheumatology |
Healthy: | No |
Age Range: | 18 - Any |
Updated: | 4/2/2016 |
Start Date: | June 2010 |
End Date: | August 2011 |
Contact: | Nabih I Abdou, MD, PhD |
Phone: | 816-531-0930 |
The purpose of this study is to study the role of the Immune System in causing arthritis in
patients with Hepatitis C.
patients with Hepatitis C.
Patients will provide one blood sample after qualifying for the study, and signing consent.
The patients will have a skin test TB, Candida, and Trichophyton placed and will read the
results themselves and mail back the card with the measurements to be recorded. Labs will
test for ESR, CBC, CRP, antiCCP, Cryoglobulins, RF, CH50, C3, C4, Flow cytometry, and would
have already been tested for HIV and Hepatitis C.
The patients will have a skin test TB, Candida, and Trichophyton placed and will read the
results themselves and mail back the card with the measurements to be recorded. Labs will
test for ESR, CBC, CRP, antiCCP, Cryoglobulins, RF, CH50, C3, C4, Flow cytometry, and would
have already been tested for HIV and Hepatitis C.
Inclusion Criteria:
- All adults 18 or older, 20 will have hep C positive with a viral load withen 6 mo. of
enrollment.
- Either interferon or antiviral naive or those who failed interferon or antiviral
therapy more than 6 mo. prior to enrollment.
- 10 normal healthy controls- Hep C neg and without osteoarthritis (OA).
Exclusion Criteria:
- HIV patients
- Those with concomitant alcoholic liver disease
- Patients with Rheumatoid Arthritis (RA) or other autoimmune disorders.
We found this trial at
1
site
Click here to add this to my saved trials